Julie B. Feder, Chief Financial Officer at Aura Biosciences, Inc. (AURA), sold 2,015 shares at $12.45 ($25K) on 2022-10-31, disclosed to the SEC on 2022-11-02.
Scheduled sale ($25k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AURA | SELL | 2023-11-07 | $47K | — | Filing → |
| AURA | SELL | 2023-11-01 | $23K | — | Filing → |